Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
The most recent EPS for Becton Dickinson and Co is $2.91, 超出預期 expectations of $2.84.
How did Becton Dickinson and Co BDX's revenue perform in the last quarter?
Becton Dickinson and Co revenue for the last quarter is $2.91
What is the revenue estimate for Becton Dickinson and Co?
According to 14 of Wall street analyst, the revenue estimate of Becton Dickinson and Co range from $5.19B to $4.79B
What's the earning quality score for Becton Dickinson and Co?
Becton Dickinson and Co has a earning quality score of A-/58.995422. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Becton Dickinson and Co report earnings?
Becton Dickinson and Co next earnings report is expected in 2026-05-10
What are Becton Dickinson and Co's expected earnings?
Becton Dickinson and Co expected earnings is $5.19B, according to wall-street analysts.
Did Becton Dickinson and Co beat earnings expectations?
Becton Dickinson and Co recent earnings of $5.25B 超出預期 expectations.